Telomerase

Is it the future diagnostic and prognostic tool in human cancer?

M. J E M F Mabruk, Cathal O'Flatharta

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

A number of methods exist to detect levels of telomerose activity and the presence of telomerase subunits in a variety of tissues. As telomerase activation seems to be an important step in tumorigenesis, accurate detection of the presence and activity of the enzyme and its subunits is vital. The original method of detecting telomerase activity was developed by Kim and coworkers in 1994, and was termed the telomeric repeat amplification protocol. This assay led to a staggering increase in the number of telomerase-associated publications in scientific journals (85 publications from 1974-1994, 5063 publications from 1994-2004). A number of methods have been described to detect telomeres and to measure their length, with the standard measurement of telomere length performed using a modification of the Southern blot protocol. RNA in situ hybridization can be performed to detect levels of the RNA component of telomerase, and standard in situ hybridization and immunohistochemistry can be applied to examine expression levels and localization of the catalytic subunit of the enzyme. Reverse transcriptase PCR has also been applied to assess expression levels of the telomerase components in various tissues. This review provides a synopsis of telomeres, telomerase, telomerase and cancer, and finally, methods for the detection of telomerase in cancer.

Original languageEnglish
Pages (from-to)907-916
Number of pages10
JournalExpert Review of Molecular Diagnostics
Volume5
Issue number6
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Telomerase
Neoplasms
Telomere
Publications
In Situ Hybridization
Enzymes
Southern Blotting
Reverse Transcriptase Polymerase Chain Reaction
Catalytic Domain
Carcinogenesis
Immunohistochemistry
RNA

Keywords

  • hTERT
  • Immunohistochemistry
  • In situ hybridization
  • Telomerase
  • Telomere
  • Telomere length
  • TRAP

ASJC Scopus subject areas

  • Genetics

Cite this

Telomerase : Is it the future diagnostic and prognostic tool in human cancer? / Mabruk, M. J E M F; O'Flatharta, Cathal.

In: Expert Review of Molecular Diagnostics, Vol. 5, No. 6, 11.2005, p. 907-916.

Research output: Contribution to journalReview article

@article{e874cd993a4c4efc8d3a97ca7682f4b6,
title = "Telomerase: Is it the future diagnostic and prognostic tool in human cancer?",
abstract = "A number of methods exist to detect levels of telomerose activity and the presence of telomerase subunits in a variety of tissues. As telomerase activation seems to be an important step in tumorigenesis, accurate detection of the presence and activity of the enzyme and its subunits is vital. The original method of detecting telomerase activity was developed by Kim and coworkers in 1994, and was termed the telomeric repeat amplification protocol. This assay led to a staggering increase in the number of telomerase-associated publications in scientific journals (85 publications from 1974-1994, 5063 publications from 1994-2004). A number of methods have been described to detect telomeres and to measure their length, with the standard measurement of telomere length performed using a modification of the Southern blot protocol. RNA in situ hybridization can be performed to detect levels of the RNA component of telomerase, and standard in situ hybridization and immunohistochemistry can be applied to examine expression levels and localization of the catalytic subunit of the enzyme. Reverse transcriptase PCR has also been applied to assess expression levels of the telomerase components in various tissues. This review provides a synopsis of telomeres, telomerase, telomerase and cancer, and finally, methods for the detection of telomerase in cancer.",
keywords = "hTERT, Immunohistochemistry, In situ hybridization, Telomerase, Telomere, Telomere length, TRAP",
author = "Mabruk, {M. J E M F} and Cathal O'Flatharta",
year = "2005",
month = "11",
doi = "10.1586/14737159.5.6.907",
language = "English",
volume = "5",
pages = "907--916",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Telomerase

T2 - Is it the future diagnostic and prognostic tool in human cancer?

AU - Mabruk, M. J E M F

AU - O'Flatharta, Cathal

PY - 2005/11

Y1 - 2005/11

N2 - A number of methods exist to detect levels of telomerose activity and the presence of telomerase subunits in a variety of tissues. As telomerase activation seems to be an important step in tumorigenesis, accurate detection of the presence and activity of the enzyme and its subunits is vital. The original method of detecting telomerase activity was developed by Kim and coworkers in 1994, and was termed the telomeric repeat amplification protocol. This assay led to a staggering increase in the number of telomerase-associated publications in scientific journals (85 publications from 1974-1994, 5063 publications from 1994-2004). A number of methods have been described to detect telomeres and to measure their length, with the standard measurement of telomere length performed using a modification of the Southern blot protocol. RNA in situ hybridization can be performed to detect levels of the RNA component of telomerase, and standard in situ hybridization and immunohistochemistry can be applied to examine expression levels and localization of the catalytic subunit of the enzyme. Reverse transcriptase PCR has also been applied to assess expression levels of the telomerase components in various tissues. This review provides a synopsis of telomeres, telomerase, telomerase and cancer, and finally, methods for the detection of telomerase in cancer.

AB - A number of methods exist to detect levels of telomerose activity and the presence of telomerase subunits in a variety of tissues. As telomerase activation seems to be an important step in tumorigenesis, accurate detection of the presence and activity of the enzyme and its subunits is vital. The original method of detecting telomerase activity was developed by Kim and coworkers in 1994, and was termed the telomeric repeat amplification protocol. This assay led to a staggering increase in the number of telomerase-associated publications in scientific journals (85 publications from 1974-1994, 5063 publications from 1994-2004). A number of methods have been described to detect telomeres and to measure their length, with the standard measurement of telomere length performed using a modification of the Southern blot protocol. RNA in situ hybridization can be performed to detect levels of the RNA component of telomerase, and standard in situ hybridization and immunohistochemistry can be applied to examine expression levels and localization of the catalytic subunit of the enzyme. Reverse transcriptase PCR has also been applied to assess expression levels of the telomerase components in various tissues. This review provides a synopsis of telomeres, telomerase, telomerase and cancer, and finally, methods for the detection of telomerase in cancer.

KW - hTERT

KW - Immunohistochemistry

KW - In situ hybridization

KW - Telomerase

KW - Telomere

KW - Telomere length

KW - TRAP

UR - http://www.scopus.com/inward/record.url?scp=27944458006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944458006&partnerID=8YFLogxK

U2 - 10.1586/14737159.5.6.907

DO - 10.1586/14737159.5.6.907

M3 - Review article

VL - 5

SP - 907

EP - 916

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 6

ER -